Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
Figure 3
PSA course after 2009/1/1 of the patient described in Figure 2 is enlarged. After surgical castration, docetaxel (70 mg/m2 per course every three weeks) was administered together with zoledronic acid (4 mg/body).
